Hillsdale Investment Management’s Zimmer Biomet ZBH Stock Holding History

Hillsdale Investment Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,507	Closed	-$345K	–	701
2020 Q1	$345K	Buy	+3,507	New	+$460K	0.04%	363
2016 Q4	–	Sell	-21	Closed	-$3K	–	552
2016 Q3	$3K	Hold	21	–	–	﹤0.01%	447
2016 Q2	$2K	Hold	21	–	–	﹤0.01%	489
2016 Q1	$2K	Hold	21	–	–	﹤0.01%	468
2015 Q4	$2K	Buy	+21	New	+$2.06K	﹤0.01%	473
2013 Q4	–	Sell	-103	Closed	-$8K	–	595
2013 Q3	$8K	Hold	103	–	–	﹤0.01%	478
2013 Q2	$7K	Buy	+103	New	+$7.7K	﹤0.01%	493

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Hillsdale Investment Management's ZBH Position: Q2 2020 in Review

Hillsdale Investment Management sold out of Zimmer Biomet (ZBH) in Q2 2020, closing a stake of 3,507 shares — an estimated $345K sold.

Hillsdale Investment Management first reported a position in ZBH in Q2 2013 and held it in 7 quarters. The position peaked at $345K in Q1 2020. 946 funds tracked by Wall St. Rank hold ZBH as of Q2 2020.

Hillsdale Investment Management reported no remaining Zimmer Biomet position as of Q2 2020 after selling out during the quarter.
Hillsdale Investment Management sold 3,507 Zimmer Biomet shares in Q2 2020, an estimated $345K.
Hillsdale Investment Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 7 quarters.
Hillsdale Investment Management's Zimmer Biomet position peaked at $345K in Q1 2020.
946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2020.

Based on Hillsdale Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.